Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: A population-level analysis

Thyroid

Volumn 23, Issue 10, 2013, Pages 1305-1311

  Kuo, Eric J ^a   Goffredo, Paolo ^b   Sosa, Julie A ^c   Roman, Sanziana A ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHI SQUARE TEST; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOBECTOMY; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; RISK FACTOR; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; CARCINOMA, LARGE CELL; CARCINOMA, PAPILLARY; COHORT STUDIES; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; ORGAN SPARING TREATMENTS; RADIOPHARMACEUTICALS; RADIOTHERAPY; SCLEROSIS; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TISSUE DISTRIBUTION; TUMOR BURDEN; UNITED STATES;

EID: 84884622986     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0563     Document Type: Conference Paper

References (52)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
2. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801-3807.
3. Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM 2011 The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231-236.
4. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y 2010 Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222-1231.
5. Yu XM, Wan Y, Sippel RS, Chen H 2011 Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18, 445 cases. Ann Surg 254:653-660.
6. Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M 1985 Papillary carcinoma. Semin Diagn Pathol 2:90-100.
7. Carcangiu ML, Bianchi S 1989 Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041-1049.
8. Carling T, Ocal IT, Udelsman R 2007 Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 31:916-923.
9. Soares J, Limbert E, Sobrinho-Simoes M 1989 Diffuse scle-rosing variant of papillary thyroid carcinoma. A clinico-pathologic study of 10 cases. Pathol Res Pract 185:200-206.
10. Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K 1990 Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer 66:2306-2312.
11. Albareda M, Puig-Domingo M, Wengrowicz S, Soldevila J, Matias-Guiu X, Caballero A, Chico A, De Leiva A 1998 Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 8:385-391.
12. Sywak M, Pasieka JL, OgilvieT2004Areviewofthyroid cancer with intermediate differentiation. J Surg Oncol 86:44-54.
13. Lam AK, Lo CY 2006 Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176-181.
14. Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E 2006 Prognostic importance of sclerosing variant in papillary thyroid carcinoma. Am Surg 72:438-444.
15. Lee JY, Shin JH, Han BK, Ko EY, Kang SS, Kim JY, Oh YL, Chung JH 2007 Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings. Thyroid 17:567-573.
16. Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A 2009 Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World J Surg 33:958-962.
17. Kazaure HS, Roman SA, Sosa JA 2012 Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43, 738 patients. Annals Surg Oncol 19:1874-1880.
18. Hawk WA, Hazard JB 1976 The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 43:207-215.
19. Gamboa-Dominguez A, Candanedo-Gonzalez F, Uribe-Uribe NO, Angeles-Angeles A 1997 Tall cell variant of papillary thyroid carcinoma. A cytohistologic correlation. Acta Cytol 41:672-676.
20. Bocklage T, DiTomasso JP, Ramzy I, Ostrowski ML 1997 Tall cell variant of papillary thyroid carcinoma: cytologic features and differential diagnostic considerations. Diagn Cy-topathol 17:25-29.
21. Ghossein R, Livolsi VA 2008 Papillary thyroid carcinoma tall cell variant. Thyroid 18:1179-1181.
22. Urano M, Kiriyama Y, Takakuwa Y, Kuroda M 2009 Tall cell variant of papillary thyroid carcinoma: Its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study. Diagn Cytopathol 37:732-737.
23. Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC 1988 Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 12:22-27.
24. Ostrowski ML, Merino MJ 1996 Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemi-cal study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 20:964-974.
25. Prendiville S, Burman KD, Ringel MD, Shmookler BM, Deeb ZE, Wolfe K, Azumi N, Wartofsky L, Sessions RB 2000 Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg 122:352-357.
26. Machens A, Holzhausen HJ, Lautenschlager C, Dralle H 2004 The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors. Langenbecks Arch Surg 389:278-282.
27. Michels JJ, Jacques M, Henry-Amar M, Bardet S 2007 Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Human Pathol 38:212-219.
28. Ghossein RA, Leboeuf R, Patel KN, Rivera M, Katabi N, Carlson DL, Tallini G, Shaha A, Singh B, Tuttle RM 2007 Tall cell variant of papillary thyroid carcinoma without extra-thyroid extension: biologic behavior and clinical implications. Thyroid 17:655-661.
29. Leung AK, Chow SM, Law SC 2008 Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Laryngoscope 118:32-38.
30. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I 2010 Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid 20:153-158.
31. Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR 2008 Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-987; discussion 987-988.
32. National Cancer Institute. Overview of the SEER program. http://seer.cancer.gov/about/overview.html (accessed on August 28, 2012).
33. Akslen LA, Varhaug JE 1990 Thyroid carcinoma with mixed tall-cell and columnar-cell features. Am J Clin Pathol 94:442-445.
34. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F 1995 Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 12:249-255.
35. Ceresini G, Corcione L, Michiara M, Sgargi P, Teresi G, Gilli A, Usberti E, Silini E, Ceda GP 2012 Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. Cancer 118:5473-5480.
36. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
37. Regalbuto C, Malandrino P, Frasca F, Pellegriti G, Le Moli R, Vigneri R, Pezzino V 2013 The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. J Endocrinol Investigat 36:249-254.
38. Regalbuto C, Malandrino P, Tumminia A, Le Moli R, Vigneri R, Pezzino V 2011 A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid 21:383-389.
39. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A 2011 Aggressive variants of papillary thyroid carcinoma. Head Neck 33:1052-1059.
40. Alvarado R, Sywak MS, Delbridge L, Sidhu SB 2009 Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 145:514-518.
41. Ohori NP, Schoedel KE 1999 Cytopathology of high-grade papillary thyroid carcinomas: tall-cell variant, diffuse sclerosing variant, and poorly differentiated papillary carcinoma. Diagn Cytopathol 20:19-23.
42. Caruso G, Tabarri B, Lucchi I, Tison V 1990 Fine needle aspiration cytology in a case of diffuse sclerosing carcinoma of the thyroid. Acta Cytol 34:352-354.
43. Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W 2009 Analysis of differential BRAF(V600E) muta-tional status in high aggressive papillary thyroid micro-carcinoma. Ann Surg Oncol 16:240-245.
44. Kwak JY, Kim EK, Chung WY, Moon HJ, Kim MJ, Choi JR 2009 Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology 253: 854-860.
45. Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM 2010 The BRAF mutation is predictive of aggressive clinicopath-ological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol 17:3294-3300.
46. Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML 2013 BRAF(V600E) mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol 26:62-70.
47. Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW, Nikiforov YE 2006 Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216-222.
48. Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW 2009 Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 41:482-487.
49. Basolo F, Torregrossa L, Giannini R, Miccoli M, Lupi C, Sensi E, Berti P, Elisei R, Vitti P, Baggiani A, Miccoli P 2010 Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 95:4197-4205.
50. Finkelstein A, Levy GH, Hui P, Prasad A, Virk R, Chhieng DC, Carling T, Roman SA, Sosa JA, Udelsman R, Theoharis CG, Prasad ML 2012 Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology 60:1052-1059.
51. Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW 2007 Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 20:779-787.
52. Theoharis C, Roman S, Sosa JA 2012 The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol 24:35-41.